| scholarly article | Q13442814 |
| P2093 | author name string | Sang Chul Lee | |
| Jong-Seok Lim | |||
| Suk Ran Yoon | |||
| Seon-Jin Lee | |||
| Hee Gu Lee | |||
| Bo-Yeon Kim | |||
| Byung Moo Oh | |||
| Yong-Kyung Choe | |||
| Jong-Tae Kim | |||
| Yun Sun Park | |||
| Hee Jun Cho | |||
| P2860 | cites work | Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 |
| Lysosomal cysteine proteases: facts and opportunities | Q24535678 | ||
| A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target | Q24623736 | ||
| Autophagy: a druggable process that is deregulated in aging and human disease | Q26863483 | ||
| Expression of type 2 cystatin genes CST1-CST5 in adult human tissues and the developing submandibular gland | Q28205247 | ||
| Gold-Based Therapeutic Agents | Q28212247 | ||
| Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2 | Q28236726 | ||
| Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
| Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? | Q29616804 | ||
| Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines | Q33547453 | ||
| Auranofin. New oral gold compound for treatment of rheumatoid arthritis | Q33569714 | ||
| Unraveling the role of proteases in cancer | Q33838143 | ||
| Autophagy in neurons: a review | Q33960743 | ||
| Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth | Q34221890 | ||
| Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia | Q34231446 | ||
| The autophagosomal-lysosomal compartment in programmed cell death | Q34355996 | ||
| Protective mechanisms by cystatin C in neurodegenerative diseases | Q34572391 | ||
| Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease? | Q34648901 | ||
| ROS, mitochondria and the regulation of autophagy | Q34679713 | ||
| Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma | Q34742203 | ||
| A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems. | Q36532821 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo | Q36771950 | ||
| Deconvoluting the context-dependent role for autophagy in cancer | Q36876716 | ||
| The roles of therapy-induced autophagy and necrosis in cancer treatment | Q37038235 | ||
| Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. | Q37182981 | ||
| Liaisons dangereuses: autophagy, neuronal survival and neurodegeneration | Q37289011 | ||
| Cancer cell killing via ROS: to increase or decrease, that is the question | Q37316371 | ||
| Cystatins and cancer | Q37409974 | ||
| Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity | Q37424088 | ||
| Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo | Q37726102 | ||
| The multiple roles of autophagy in cancer | Q37840892 | ||
| Mitochondrial ROS generation for regulation of autophagic pathways in cancer | Q37939467 | ||
| Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. | Q38369963 | ||
| Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response | Q38644547 | ||
| Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma | Q38878577 | ||
| The cystatins: a diverse superfamily of cysteine peptidase inhibitors | Q39767537 | ||
| Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase | Q39815001 | ||
| Identification of Cystatin SN as a novel tumor marker for colorectal cancer | Q39840201 | ||
| Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer | Q39848064 | ||
| Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species | Q40046145 | ||
| Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells | Q40071790 | ||
| Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. | Q40167113 | ||
| Mechanisms of intralysosomal degradation with special reference to autophagocytosis and heterophagocytosis of cell organelles | Q40318172 | ||
| Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. | Q40748964 | ||
| Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease. | Q40818076 | ||
| Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors | Q41482008 | ||
| Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity | Q41832100 | ||
| The thioredoxin system in breast cancer cell invasion and migration | Q42003950 | ||
| N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway | Q44545256 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| autophagy | Q288322 | ||
| cell death | Q2383867 | ||
| P304 | page(s) | e2682 | |
| P577 | publication date | 2017-03-16 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer | |
| P478 | volume | 8 |
| Q92533634 | Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer |
| Q90435498 | Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients |
| Q33593007 | Opuntia spp.: Characterization and Benefits in Chronic Diseases. |
| Q64065794 | Research progress of cystatin SN in cancer |
| Q87866316 | Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma |
| Q95649089 | The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells |
Search more.